Romeo R. Galang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Romeo R. Galang has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
- Regina M. Simeone
Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia
4 shared publications - Sascha Ellington
Centers for Disease Control and Prevention
4 shared publications Van T. Tong
Centers for Disease Control and Prevention COVID-19 Response, Epidemiology Task Force, Atlanta, USA
4 shared publications- Jean Y. Ko
Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
3 shared publications - Lauren B. Zapata
Division of Reproductive Health; Centers for Disease Control and Prevention; Atlanta Georgia USA
3 shared publications - Carla L. DeSisto
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
2 shared publications
Latest Publications
- Open Access
- 19 April 2026
- Published by Elsevier in SSRN Electronic Journal
Maternal–Fetal Immune Remodeling After Non-Severe SARS-CoV-2 in Pregnancy: A Prospective Kenyan Cohort Study
Background: Most maternal SARS-CoV-2 infections are non-severe, yet the maternal–neonatal immune consequences of non-severe infection remain less defined, particularly in African maternal–newborn cohorts that remain underrepresented in immunologic studies of emerging infections. We investigated whether non-severe maternal SARS-CoV-2 infection altered maternal and cord blood immune mediator profiles in a prospective Kenyan pregnancy cohort.Methods: In a prospective cohort at two Kenyan hospitals before vaccine rollout, pregnant women enrolled at less than 31 weeks’ gestation were followed to delivery. Of 430 enrolled participants (298 eligible), we profiled all 8 symptomatic SARS-CoV-2 cases together with 13 randomly selected controls and 13 randomly selected asymptomatic sero-converters. We measured 39 immune mediators and combined biomarker-level analyses of maternal trajectories and adjusted cord blood differences with profile-level analyses of maternal–cord compartmentalization.Findings: Acute symptomatic COVID-19 was associated with elevated IP-10, IL-1RA, GRO-α, MCP-1, M-CSF, IL-7, IL-18, IL-25, PDGF-AA, and PDGF-AB/BB from baseline. Most elevations were resolved by convalescence, but RANTES and GRO-α fell below enrollment levels. Maternal and cord blood profiles remained distinct, but COVID-19 altered compartmentalization. After adjustment for maternal concentrations, cord blood IL-12p40, EGF, G-CSF, M-CSF, IL-8, and Eotaxin were lower in COVID-19 than in control dyads.Interpretation: Non-severe maternal SARS-CoV-2 infection elicited a selective acute response engaging chemokine, regulatory, and growth factor pathways, without broad hypercytokinaemia, followed by chemokine suppression at convalescence and attenuated cord concentrations of selected immune mediators at delivery. These findings suggest that pathogens that perturb the maternal–fetal interface may introduce vulnerabilities not apparent through routine case-based surveillance and could inform maternal and early-life protection strategies in future outbreaks.
- 19 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMaternal–Fetal Immune Remodeling After Non-Severe SARS-CoV-2 in Pregnancy: A Prospective Kenyan Cohort Study
Background: Most maternal SARS-CoV-2 infections are non-severe, yet the maternal–neonatal immune consequences of non-severe infection remain less defined, particularly in African maternal–newborn cohorts that remain underrepresented in immunologic studies of emerging infections. We investigated whether non-severe maternal SARS-CoV-2 infection altered maternal and cord blood immune mediator profiles in a prospective Kenyan pregnancy cohort.Methods: In a prospective cohort at two Kenyan hospitals before vaccine rollout, pregnant women enrolled at less than 31 weeks’ gestation were followed to delivery. Of 430 enrolled participants (298 eligible), we profiled all 8 symptomatic SARS-CoV-2 cases together with 13 randomly selected controls and 13 randomly selected asymptomatic sero-converters. We measured 39 immune mediators and combined biomarker-level analyses of maternal trajectories and adjusted cord blood differences with profile-level analyses of maternal–cord compartmentalization.Findings: Acute symptomatic COVID-19 was associated with elevated IP-10, IL-1RA, GRO-α, MCP-1, M-CSF, IL-7, IL-18, IL-25, PDGF-AA, and PDGF-AB/BB from baseline. Most elevations were resolved by convalescence, but RANTES and GRO-α fell below enrollment levels. Maternal and cord blood profiles remained distinct, but COVID-19 altered compartmentalization. After adjustment for maternal concentrations, cord blood IL-12p40, EGF, G-CSF, M-CSF, IL-8, and Eotaxin were lower in COVID-19 than in control dyads.Interpretation: Non-severe maternal SARS-CoV-2 infection elicited a selective acute response engaging chemokine, regulatory, and growth factor pathways, without broad hypercytokinaemia, followed by chemokine suppression at convalescence and attenuated cord concentrations of selected immune mediators at delivery. These findings suggest that pathogens that perturb the maternal–fetal interface may introduce vulnerabilities not apparent through routine case-based surveillance and could inform maternal and early-life protection strategies in future outbreaks.
- 8 October 2024
- Published by SAGE Publications in Journal of Women's Health
- Vol. 33 (10) , 1289-1295
Strengthening Maternal and Infant Health Resilience Before Weather and Climate Disasters: Preparedness Resources from CDC’s Division of Reproductive Health
This report describes opportunities to address emergency preparedness to incorporate the needs of pregnant and postpartum populations. This report briefly summarizes data on the impacts of weather and climate disasters on maternal and infant health and outlines opportunities for individuals, health care providers, and public health practitioners to increase capacity to prepare for these occurrences, which are becoming more frequent and costly. Specific resources from the U.S. Centers for Disease Control and Prevention’s Division of Reproductive Health are shared to support individual preparedness, communication of disaster safety messages, and emergency preparedness planning capacity among health care providers and health departments.
- 8 October 2024
- Published by SAGE Publications in Journal of Women's Health
- Vol. 33 (10) , 1289-1295
Strengthening Maternal and Infant Health Resilience Before Weather and Climate Disasters: Preparedness Resources from CDC’s Division of Reproductive Health
This report describes opportunities to address emergency preparedness to incorporate the needs of pregnant and postpartum populations. This report briefly summarizes data on the impacts of weather and climate disasters on maternal and infant health and outlines opportunities for individuals, health care providers, and public health practitioners to increase capacity to prepare for these occurrences, which are becoming more frequent and costly. Specific resources from the U.S. Centers for Disease Control and Prevention’s Division of Reproductive Health are shared to support individual preparedness, communication of disaster safety messages, and emergency preparedness planning capacity among health care providers and health departments.
- Open Access
Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data
Background Severe maternal morbidity (SMM) is broadly defined as an unexpected and potentially life-threatening event associated with labor and delivery. The Centers for Disease Control and Prevention (CDC) produced 21 different indicators based on International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) hospital diagnostic and procedure codes to identify cases of SMM. Objectives To examine existing SMM indicators and determine which indicators identified the most in-hospital mortality at delivery hospitalization. Methods Data from the 1993–2015 and 2017–2019 Healthcare Cost and Utilization Project’s National Inpatient Sample were used to report SMM indicator-specific prevalences, in-hospital mortality rates, and population attributable fractions (PAF) of mortality. We hierarchically ranked indicators by their overall PAF of in-hospital mortality. Predictive modeling determined if SMM prevalence remained comparable after transition to ICD-10-CM coding. Results The study population consisted of 18,198,934 hospitalizations representing 87,864,173 US delivery hospitalizations. The 15 top ranked indicators identified 80% of in-hospital mortality; the proportion identified by the remaining indicators was negligible (2%). The top 15 indicators were: restoration of cardiac rhythm; cardiac arrest; mechanical ventilation; tracheostomy; amniotic fluid embolism; aneurysm; acute respiratory distress syndrome; acute myocardial infarction; shock; thromboembolism, pulmonary embolism; cerebrovascular disorders; sepsis; both DIC and blood transfusion; acute renal failure; and hysterectomy. The overall prevalence of the top 15 ranked SMM indicators (∼22,000 SMM cases per year) was comparable after transition to ICD-10-CM coding. Conclusions We determined the 15 indicators that identified the most in-hospital mortality at delivery hospitalization in the US. Continued testing of SMM indicators can improve measurement and surveillance of the most severe maternal complications at the population level.
Open AccessRanked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data
Background Severe maternal morbidity (SMM) is broadly defined as an unexpected and potentially life-threatening event associated with labor and delivery. The Centers for Disease Control and Prevention (CDC) produced 21 different indicators based on International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) hospital diagnostic and procedure codes to identify cases of SMM. Objectives To examine existing SMM indicators and determine which indicators identified the most in-hospital mortality at delivery hospitalization. Methods Data from the 1993–2015 and 2017–2019 Healthcare Cost and Utilization Project’s National Inpatient Sample were used to report SMM indicator-specific prevalences, in-hospital mortality rates, and population attributable fractions (PAF) of mortality. We hierarchically ranked indicators by their overall PAF of in-hospital mortality. Predictive modeling determined if SMM prevalence remained comparable after transition to ICD-10-CM coding. Results The study population consisted of 18,198,934 hospitalizations representing 87,864,173 US delivery hospitalizations. The 15 top ranked indicators identified 80% of in-hospital mortality; the proportion identified by the remaining indicators was negligible (2%). The top 15 indicators were: restoration of cardiac rhythm; cardiac arrest; mechanical ventilation; tracheostomy; amniotic fluid embolism; aneurysm; acute respiratory distress syndrome; acute myocardial infarction; shock; thromboembolism, pulmonary embolism; cerebrovascular disorders; sepsis; both DIC and blood transfusion; acute renal failure; and hysterectomy. The overall prevalence of the top 15 ranked SMM indicators (∼22,000 SMM cases per year) was comparable after transition to ICD-10-CM coding. Conclusions We determined the 15 indicators that identified the most in-hospital mortality at delivery hospitalization in the US. Continued testing of SMM indicators can improve measurement and surveillance of the most severe maternal complications at the population level.
- 2 September 2023
- Published by Springer Nature in Journal of Perinatology
- Vol. 44 (1) , 20-27
Differences in delivery hospitalization experiences during the COVID-19 pandemic by maternal race and ethnicity, Pregnancy Risk Assessment Monitoring System, 2020
Objective We investigated maternal COVID-19 related experiences during delivery hospitalizations, and whether experiences differed by maternal race and ethnicity. Study design Data from the Pregnancy Risk Assessment Monitoring System among women with live births between April–December 2020 were used. Adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) estimated associations between maternal race and ethnicity and COVID-19 related delivery experiences. Results Among 12,879 women, 3.6% reported infant separation and 1.8% reported not being allowed support persons. Compared with non-Hispanic White women, American Indian/Alaska Native (AI/AN) (aPR = 2.7; CI: 1.2–6.2), Hispanic (aPR = 2.2; CI: 1.5–3.1), non-Hispanic Black (aPR = 2.4; CI: 1.7–3.6), and non-Hispanic Asian (aPR = 2.8; CI: 1.6–4.9) women reported more infant separation due to COVID-19. Not being allowed support persons was more common among AI/AN (aPR = 5.2; CI: 1.8–14.8) and non-Hispanic Black (aPR = 2.3; CI: 1.3–4.1) women. Conclusions COVID-19 related delivery hospitalization experiences were unequally distributed among racial and ethnic minorities.
- 2 September 2023
- Published by Springer Nature in Journal of Perinatology
- Vol. 44 (1) , 20-27
Differences in delivery hospitalization experiences during the COVID-19 pandemic by maternal race and ethnicity, Pregnancy Risk Assessment Monitoring System, 2020
Objective We investigated maternal COVID-19 related experiences during delivery hospitalizations, and whether experiences differed by maternal race and ethnicity. Study design Data from the Pregnancy Risk Assessment Monitoring System among women with live births between April–December 2020 were used. Adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) estimated associations between maternal race and ethnicity and COVID-19 related delivery experiences. Results Among 12,879 women, 3.6% reported infant separation and 1.8% reported not being allowed support persons. Compared with non-Hispanic White women, American Indian/Alaska Native (AI/AN) (aPR = 2.7; CI: 1.2–6.2), Hispanic (aPR = 2.2; CI: 1.5–3.1), non-Hispanic Black (aPR = 2.4; CI: 1.7–3.6), and non-Hispanic Asian (aPR = 2.8; CI: 1.6–4.9) women reported more infant separation due to COVID-19. Not being allowed support persons was more common among AI/AN (aPR = 5.2; CI: 1.8–14.8) and non-Hispanic Black (aPR = 2.3; CI: 1.3–4.1) women. Conclusions COVID-19 related delivery hospitalization experiences were unequally distributed among racial and ethnic minorities.
- Open Access
- 6 June 2023
- Published by Springer Nature in Research Square
Differences in delivery hospitalization experiences during the COVID-19 pandemic by maternal race and ethnicity, Pregnancy Risk Assessment Monitoring System, 2020
Objective We investigated maternal COVID-19 related experiences during delivery hospitalizations, and whether experiences differed by maternal race and ethnicity. Study design Data from the Pregnancy Risk Assessment Monitoring System among women with live births between April–December 2020 were used. Adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) estimated associations between maternal race and ethnicity and COVID-19 related delivery experiences. Results Among 12 879 women, 3.6% reported infant separation and 1.8% reported not being allowed support persons. Compared with non-Hispanic White women, American Indian/Alaska Native (AI/AN) (aPR=2.7; CI: 1.2-6.3), Hispanic (aPR=2.2; CI: 1.5-3.1), non-Hispanic Black (aPR= 2.4; CI: 1.7-3.5), and non-Hispanic Asian (aPR= 2.9; CI: 1.7-4.9) women reported more infant separation due to COVID-19. Not being allowed support persons was more common among AI/AN (aPR=5.3; CI: 1.8-15.4) and non-Hispanic Black (aPR=2.3; CI: 1.3-4.1) women. Conclusions COVID-19 related delivery hospitalization experiences were unequally distributed among racial and ethnic minorities.
- 6 June 2023
- Published by Springer Nature in Research Square
Open AccessDifferences in delivery hospitalization experiences during the COVID-19 pandemic by maternal race and ethnicity, Pregnancy Risk Assessment Monitoring System, 2020
Objective We investigated maternal COVID-19 related experiences during delivery hospitalizations, and whether experiences differed by maternal race and ethnicity. Study design Data from the Pregnancy Risk Assessment Monitoring System among women with live births between April–December 2020 were used. Adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) estimated associations between maternal race and ethnicity and COVID-19 related delivery experiences. Results Among 12 879 women, 3.6% reported infant separation and 1.8% reported not being allowed support persons. Compared with non-Hispanic White women, American Indian/Alaska Native (AI/AN) (aPR=2.7; CI: 1.2-6.3), Hispanic (aPR=2.2; CI: 1.5-3.1), non-Hispanic Black (aPR= 2.4; CI: 1.7-3.5), and non-Hispanic Asian (aPR= 2.9; CI: 1.7-4.9) women reported more infant separation due to COVID-19. Not being allowed support persons was more common among AI/AN (aPR=5.3; CI: 1.8-15.4) and non-Hispanic Black (aPR=2.3; CI: 1.3-4.1) women. Conclusions COVID-19 related delivery hospitalization experiences were unequally distributed among racial and ethnic minorities.
- 1 April 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (4) , 472-479
Cardiac Arrest During Delivery Hospitalization
Estimates of cardiac arrest occurring during delivery guide evidence-based strategies to reduce pregnancy-related death. To investigate rate of, maternal characteristics associated with, and survival after cardiac arrest during delivery hospitalization. Retrospective cohort study. U.S. acute care hospitals, 2017 to 2019. Delivery hospitalizations among women aged 12 to 55 years included in the National Inpatient Sample database. Delivery hospitalizations, cardiac arrest, underlying medical conditions, obstetric outcomes, and severe maternal complications were identified using codes from the International Classification of Diseases, 10th Revision, Clinical Modification. Survival to hospital discharge was based on discharge disposition. Among 10 921 784 U.S. delivery hospitalizations, the cardiac arrest rate was 13.4 per 100 000. Of the 1465 patients who had cardiac arrest, 68.6% (95% CI, 63.2% to 74.0%) survived to hospital discharge. Cardiac arrest was more common among patients who were older, were non-Hispanic Black, had Medicare or Medicaid, or had underlying medical conditions. Acute respiratory distress syndrome was the most common co-occurring diagnosis (56.0% [CI, 50.2% to 61.7%]). Among co-occurring procedures or interventions examined, mechanical ventilation was the most common (53.2% [CI, 47.5% to 59.0%]). The rate of survival to hospital discharge after cardiac arrest was lower with co-occurring disseminated intravascular coagulation (DIC) without or with transfusion (50.0% [CI, 35.8% to 64.2%] or 54.3% [CI, 39.2% to 69.5%], respectively). Cardiac arrests occurring outside delivery hospitalizations were not included. The temporality of arrest relative to the delivery or other maternal complications is unknown. Data do not distinguish cause of cardiac arrest, such as pregnancy-related complications or other underlying causes among pregnant women. Cardiac arrest was observed in approximately 1 in 9000 delivery hospitalizations, among which nearly 7 in 10 women survived to hospital discharge. Survival was lowest during hospitalizations with co-occurring DIC. None.
- 1 April 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (4) , 472-479
Cardiac Arrest During Delivery Hospitalization
Estimates of cardiac arrest occurring during delivery guide evidence-based strategies to reduce pregnancy-related death. To investigate rate of, maternal characteristics associated with, and survival after cardiac arrest during delivery hospitalization. Retrospective cohort study. U.S. acute care hospitals, 2017 to 2019. Delivery hospitalizations among women aged 12 to 55 years included in the National Inpatient Sample database. Delivery hospitalizations, cardiac arrest, underlying medical conditions, obstetric outcomes, and severe maternal complications were identified using codes from the International Classification of Diseases, 10th Revision, Clinical Modification. Survival to hospital discharge was based on discharge disposition. Among 10 921 784 U.S. delivery hospitalizations, the cardiac arrest rate was 13.4 per 100 000. Of the 1465 patients who had cardiac arrest, 68.6% (95% CI, 63.2% to 74.0%) survived to hospital discharge. Cardiac arrest was more common among patients who were older, were non-Hispanic Black, had Medicare or Medicaid, or had underlying medical conditions. Acute respiratory distress syndrome was the most common co-occurring diagnosis (56.0% [CI, 50.2% to 61.7%]). Among co-occurring procedures or interventions examined, mechanical ventilation was the most common (53.2% [CI, 47.5% to 59.0%]). The rate of survival to hospital discharge after cardiac arrest was lower with co-occurring disseminated intravascular coagulation (DIC) without or with transfusion (50.0% [CI, 35.8% to 64.2%] or 54.3% [CI, 39.2% to 69.5%], respectively). Cardiac arrests occurring outside delivery hospitalizations were not included. The temporality of arrest relative to the delivery or other maternal complications is unknown. Data do not distinguish cause of cardiac arrest, such as pregnancy-related complications or other underlying causes among pregnant women. Cardiac arrest was observed in approximately 1 in 9000 delivery hospitalizations, among which nearly 7 in 10 women survived to hospital discharge. Survival was lowest during hospitalizations with co-occurring DIC. None.
- 4 August 2022
- Published by Springer Nature in Journal of Perinatology
- Vol. 42 (10) , 1328-1337
Preterm birth among pregnant persons with severe acute respiratory syndrome Coronavirus 2 infection
Objective We examined the relationship between trimester of SARS-CoV-2 infection, illness severity, and risk for preterm birth. Study design We analyzed data for 6336 pregnant persons with SARS-CoV-2 infection in 2020 in the United States. Risk ratios for preterm birth were calculated for illness severity, trimester of infection, and illness severity stratified by trimester of infection adjusted for age, selected underlying medical conditions, and pregnancy complications. Result Pregnant persons with critical COVID-19 or asymptomatic infection, compared to mild COVID-19, in the second or third trimester were at increased risk of preterm birth. Pregnant persons with moderate-to-severe COVID-19 did not show increased risk of preterm birth in any trimester. Conclusion Critical COVID-19 in the second or third trimester was associated with increased risk of preterm birth. This finding can be used to guide prevention strategies, including vaccination, and inform clinical practices for pregnant persons.
- 4 August 2022
- Published by Springer Nature in Journal of Perinatology
- Vol. 42 (10) , 1328-1337
Preterm birth among pregnant persons with severe acute respiratory syndrome Coronavirus 2 infection
Objective We examined the relationship between trimester of SARS-CoV-2 infection, illness severity, and risk for preterm birth. Study design We analyzed data for 6336 pregnant persons with SARS-CoV-2 infection in 2020 in the United States. Risk ratios for preterm birth were calculated for illness severity, trimester of infection, and illness severity stratified by trimester of infection adjusted for age, selected underlying medical conditions, and pregnancy complications. Result Pregnant persons with critical COVID-19 or asymptomatic infection, compared to mild COVID-19, in the second or third trimester were at increased risk of preterm birth. Pregnant persons with moderate-to-severe COVID-19 did not show increased risk of preterm birth in any trimester. Conclusion Critical COVID-19 in the second or third trimester was associated with increased risk of preterm birth. This finding can be used to guide prevention strategies, including vaccination, and inform clinical practices for pregnant persons.
- 15 February 2022
- Published by Springer Nature in Journal of Perinatology
- Vol. 42 (5) , 617-623
Changes in rates of adverse pregnancy outcomes during the COVID-19 pandemic: a cross-sectional study in the United States, 2019–2020
Objective Our objective was to assess differences in pregnancy outcomes during the COVID-19 pandemic compared to the previous year. Study design In a cross-sectional study of delivery hospitalizations in the Premier Healthcare Database Special COVID-19 Release, we assessed differences in selected maternal and pregnancy outcomes occurring April–December in 2019 and 2020 in the United States. Result Among 663,620 deliveries occurring in 2019 and 614,093 deliveries occurring in 2020, we observed an increase in in-hospital maternal death from 2019 to 2020, which was no longer statistically significant after excluding deliveries with a COVID-19 diagnosis. Intensive care unit admission and preterm birth decreased from 2019 to 2020. There was no difference in the prevalence of most other outcomes examined. Conclusion The full impact of the COVID-19 pandemic on maternal and pregnancy outcomes remains to be understood. Most outcomes investigated experienced minimal change from 2019 to 2020.
- 15 February 2022
- Published by Springer Nature in Journal of Perinatology
- Vol. 42 (5) , 617-623
Changes in rates of adverse pregnancy outcomes during the COVID-19 pandemic: a cross-sectional study in the United States, 2019–2020
Objective Our objective was to assess differences in pregnancy outcomes during the COVID-19 pandemic compared to the previous year. Study design In a cross-sectional study of delivery hospitalizations in the Premier Healthcare Database Special COVID-19 Release, we assessed differences in selected maternal and pregnancy outcomes occurring April–December in 2019 and 2020 in the United States. Result Among 663,620 deliveries occurring in 2019 and 614,093 deliveries occurring in 2020, we observed an increase in in-hospital maternal death from 2019 to 2020, which was no longer statistically significant after excluding deliveries with a COVID-19 diagnosis. Intensive care unit admission and preterm birth decreased from 2019 to 2020. There was no difference in the prevalence of most other outcomes examined. Conclusion The full impact of the COVID-19 pandemic on maternal and pregnancy outcomes remains to be understood. Most outcomes investigated experienced minimal change from 2019 to 2020.
- 5 November 2021
- Published by Elsevier in Contraception
- Vol. 107, 68-73
Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016–17 Zika virus outbreak
- 5 November 2021
- Published by Elsevier in Contraception
- Vol. 107, 68-73
Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016–17 Zika virus outbreak
- Open Access
- 12 October 2021
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 6 (4) , 183
Pregnancy, Birth, Infant, and Early Childhood Neurodevelopmental Outcomes among a Cohort of Women with Symptoms of Zika Virus Disease during Pregnancy in Three Surveillance Sites, Project Vigilancia de Embarazadas con Zika (VEZ), Colombia, 2016–2018
Project Vigilancia de Embarazadas con Zika (VEZ), an intensified surveillance of pregnant women with symptoms of the Zika virus disease (ZVD) in Colombia, aimed to evaluate the relationship between symptoms of ZVD during pregnancy and adverse pregnancy, birth, and infant outcomes and early childhood neurodevelopmental outcomes. During May–November 2016, pregnant women in three Colombian cities who were reported with symptoms of ZVD to the national surveillance system, or with symptoms of ZVD visiting participating clinics, were enrolled in Project VEZ. Data from maternal and pediatric (up to two years of age) medical records were abstracted. Available maternal specimens were tested for the presence of the Zika virus ribonucleic acid and/or anti-Zika virus immunoglobulin antibodies. Of 1213 enrolled pregnant women with symptoms of ZVD, 1180 had a known pregnancy outcome. Results of the Zika virus laboratory testing were available for 569 (48.2%) pregnancies with a known pregnancy outcome though testing timing varied and was often distal to the timing of symptoms; 254 (21.5% of the whole cohort; 44.6% of those with testing results) were confirmed or presumptive positive for the Zika virus infection. Of pregnancies with a known outcome, 50 (4.2%) fetuses/infants had Zika-associated brain or eye defects, which included microcephaly at birth. Early childhood adverse neurodevelopmental outcomes were more common among those with Zika-associated birth defects than among those without and more common among those with laboratory evidence of a Zika virus infection compared with the full cohort. The proportion of fetuses/infants with any Zika-associated brain or eye defect was consistent with the proportion seen in other studies. Enhancements to Colombia’s existing national surveillance enabled the assessment of adverse outcomes associated with ZVD in pregnancy.
- 12 October 2021
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 6 (4) , 183
Open AccessPregnancy, Birth, Infant, and Early Childhood Neurodevelopmental Outcomes among a Cohort of Women with Symptoms of Zika Virus Disease during Pregnancy in Three Surveillance Sites, Project Vigilancia de Embarazadas con Zika (VEZ), Colombia, 2016–2018
Project Vigilancia de Embarazadas con Zika (VEZ), an intensified surveillance of pregnant women with symptoms of the Zika virus disease (ZVD) in Colombia, aimed to evaluate the relationship between symptoms of ZVD during pregnancy and adverse pregnancy, birth, and infant outcomes and early childhood neurodevelopmental outcomes. During May–November 2016, pregnant women in three Colombian cities who were reported with symptoms of ZVD to the national surveillance system, or with symptoms of ZVD visiting participating clinics, were enrolled in Project VEZ. Data from maternal and pediatric (up to two years of age) medical records were abstracted. Available maternal specimens were tested for the presence of the Zika virus ribonucleic acid and/or anti-Zika virus immunoglobulin antibodies. Of 1213 enrolled pregnant women with symptoms of ZVD, 1180 had a known pregnancy outcome. Results of the Zika virus laboratory testing were available for 569 (48.2%) pregnancies with a known pregnancy outcome though testing timing varied and was often distal to the timing of symptoms; 254 (21.5% of the whole cohort; 44.6% of those with testing results) were confirmed or presumptive positive for the Zika virus infection. Of pregnancies with a known outcome, 50 (4.2%) fetuses/infants had Zika-associated brain or eye defects, which included microcephaly at birth. Early childhood adverse neurodevelopmental outcomes were more common among those with Zika-associated birth defects than among those without and more common among those with laboratory evidence of a Zika virus infection compared with the full cohort. The proportion of fetuses/infants with any Zika-associated brain or eye defect was consistent with the proportion seen in other studies. Enhancements to Colombia’s existing national surveillance enabled the assessment of adverse outcomes associated with ZVD in pregnancy.